SFCC Sfbc (MM)

SFBC International, Inc. (NASDAQ:SFCC), a provider of drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies, announced today that it plans to release its financial results for the fourth quarter and full year 2005 on Thursday, March 2, 2006, after the market closes. In addition, the Company plans to host a conference call and Webcast to review the results at 8:30 a.m. Eastern Time on Friday, March 3, 2006. To access the conference call, please dial the following teleconference number (877) 691-0878 (U.S.) or (973) 582-2773 (International) or to listen to the simultaneous Webcast, please visit http://www.sfbci.com. For those unable to access the live conference, there will be an audio replay available from March 3, 2006 at approximately 11:00 a.m. Eastern Time through March 17, 2006 at 11:59 p.m. Eastern Time. To listen to the audio replay, please dial (877) 519-4471 (U.S.) or (973) 341-3080 (International) and use the following replay pin code: 7081622. A replay of the live Webcast will also be available at http://www.sfbci.com approximately two hours after the live call ends through April 2, 2006 at 11:59 p.m. Eastern Time. About SFBC International, Inc. SFBC International, Inc. provides early through late stage clinical drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies around the world. SFBC has more than 30 offices located in North America, Europe (including Central and Eastern Europe), South America, Asia, and Australia. In early clinical development services, SFBC specializes primarily in the areas of Phase I and early Phase II clinical trials and bioanalytical laboratory services, including early clinical pharmacology. SFBC also provides late stage clinical development services globally that focus on Phase II through IV clinical trials. SFBC also offers a range of complementary services, including data management and biostatistics, central laboratory services, medical and scientific affairs, regulatory affairs and submissions, and clinical IT solutions. Additional information is available on SFBC's website at http://www.sfbci.com.